Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SCN1A | P35498 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3425309 | 0.86 | LMNA (0.33) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL13310006 | 0.83 | LMNA (0.33) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL3425481 | 0.83 | LMNA (0.33) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL3221660 | 0.82 | LMNA (0.34) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL6021947 | 0.82 | LMNA (0.33) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL6026322 | 0.81 | CYP1A2 (0.41) | CYP1A2RAB9AMAPTMEN1KMT2A | |
| SCHEMBL3431893 | 0.80 | POLB (0.33) | POLBKDM4EMAPTMLYCDABCB11 | |
| SCHEMBL13309995 | 0.79 | POLB (0.39) | LMNAMAPK1POLBCYP1A2MAOA | |
| SCHEMBL8899809 | 0.78 | MAPT (0.44) | MAPK1POLBKDM4ERAB9AMAPT | |
| SCHEMBL8898434 | 0.78 | TSHR (0.44) | LMNAMAPK1POLBCYP1A2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2664629-B1 | Functionalised photoinitiators | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-2664629-B1 | Functionalised photoinitiators | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-1711862-B1 | FUNCTIONALIZED PHOTOINITIATORS | BASF SE (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-1711862-B1 | FUNCTIONALIZED PHOTOINITIATORS | BASF SE (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-2664629-A1 | Functionalised photoinitiators | Ciba Holding Inc. (CH) | 2013-11-20 | — | — | EP | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732504-B2 | Functionalized photoinitiators | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-06-08 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| US-20080021126-A1 | Functionalized Photoinitiators | IGM GROUP B.V. (NL) | 2008-01-24 | — | — | US | disclosed |
| EP-1711862-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005076074-A2 | FUNCTIONALIZED PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021126-A1 | Functionalized Photoinitiators | PPOX, TYR, CYP1A1 | LMNA 2359/4885MAPK1 3145/4885POLB 2115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.